Search by Drug Name or NDC

    NDC 63187-0955-24 Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5; 120 mg/1; mg/1 Details

    Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5; 120 mg/1; mg/1

    Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Proficient Rx LP. The primary component is CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 63187-0955
    Product ID 63187-955_0a08231c-188b-4c9a-8680-d43152d71983
    Associated GPIs 43993002277420
    GCN Sequence Number 048415
    GCN Sequence Number Description cetirizine HCl/pseudoephedrine TAB ER 12H 5 MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 13866
    HICL Sequence Number 022864
    HICL Sequence Number Description CETIRIZINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cetirizine HCl, Pseudoephedrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Proficient Rx LP
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077170
    Listing Certified Through 2024-12-31

    Package

    NDC 63187-0955-24 (63187095524)

    NDC Package Code 63187-955-24
    Billing NDC 63187095524
    Package 24 BLISTER PACK in 1 CARTON (63187-955-24) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2018-01-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 5d91286c-5650-462f-bd3d-f3b2387afcde Details

    Revised: 1/2021